Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle.

Skeletal muscle development and growth are regulated through multiple signaling pathways that include insulin-like growth factor I (IGF-I) and calcineurin activation of nuclear factor of activated T cell (NFAT) transcription factors. The developmental regulation and molecular mechanisms that control IGF-I gene expression in murine embryos and in differentiating C2C12 skeletal myocytes were examined. IGF-I is expressed in developing skeletal muscle, and its embryonic expression is significantly reduced in embryos lacking both NFATc3 and NFATc4. During development, the IGF-I exon 1 promoter is active in multiple organ systems, including skeletal muscle, whereas the alternative exon 2 promoter is expressed predominantly in the liver. The IGF-I exon 1 promoter flanking sequence includes two highly conserved regions that contain NFAT consensus binding sequences. One of these conserved regions contains a calcineurin/NFAT-responsive regulatory region that is preferentially activated by NFATc3 in C2C12 skeletal muscle cells and NIH3T3 fibroblasts. This NFAT-responsive region contains three clustered NFAT consensus binding sequences, and mutagenesis experiments demonstrated the requirement for two of these in calcineurin or NFATc3 responsiveness. Chromatin immunoprecipitation analyses demonstrated that endogenous IGF-I genomic sequences containing these conserved NFAT binding sequences interact preferentially with NFATc3 in C2C12 cells. Together, these experiments demonstrated that a NFAT-rich regulatory element in the IGF-I exon 1 promoter flanking region is responsive to calcineurin signaling and NFAT activation in skeletal muscle cells. The identification of a calcineurin/NFAT-responsive element in the IGF-I gene represents a potential mechanism of intersection of these signaling pathways in the control of muscle development and homeostasis.

[1]  T. Kealey,et al.  An E box in the exon 1 promoter regulates insulin-like growth factor-I expression in differentiating muscle cells. , 2006, American journal of physiology. Cell physiology.

[2]  K. Yutzey,et al.  BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. , 2006, Developmental biology.

[3]  T. Shen,et al.  Activity- and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers. , 2006, Molecular biology of the cell.

[4]  Honglin Jiang,et al.  Characterization of Distinct Stat5b Binding Sites That Mediate Growth Hormone-stimulated IGF-I Gene Transcription* , 2006, Journal of Biological Chemistry.

[5]  Richard T. Lee,et al.  Transgenic Overexpression of Locally Acting Insulin-Like Growth Factor-1 Inhibits Ubiquitin-Mediated Muscle Atrophy in Chronic Left-Ventricular Dysfunction , 2005, Circulation research.

[6]  A. Bartke.  Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/en.2005-0411 Minireview: Role of the Growth Hormone/Insulin-Like Growth Factor System in Mammalian Aging , 2022 .

[7]  G. Goldspink.  Mechanical signals, IGF-I gene splicing, and muscle adaptation. , 2005, Physiology.

[8]  N. Rosenthal,et al.  Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. , 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[9]  Lior Pachter,et al.  VISTA: computational tools for comparative genomics , 2004, Nucleic Acids Res..

[10]  J. Neilson,et al.  Genetic Loss of Calcineurin Blocks Mechanical Overload-induced Skeletal Muscle Fiber Type Switching but Not Hypertrophy* , 2004, Journal of Biological Chemistry.

[11]  A. Imbalzano,et al.  of the Peroxisome Proliferator-Activated Receptor � Nuclear Hormone Receptor , 2003 .

[12]  E. Dodou,et al.  HRC Is a Direct Transcriptional Target of MEF2 during Cardiac, Skeletal, and Arterial Smooth Muscle Development In Vivo , 2004, Molecular and Cellular Biology.

[13]  K. Yutzey,et al.  Differential Expression and Function of Tbx5 and Tbx20 in Cardiac Development* , 2004, Journal of Biological Chemistry.

[14]  K. Yutzey,et al.  DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice. , 2004, Developmental biology.

[15]  Katherine E Yutzey,et al.  Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. , 2004, Developmental biology.

[16]  Jean-Michel Claverie,et al.  FusionDB: a database for in-depth analysis of prokaryotic gene fusion events , 2004, Nucleic Acids Res..

[17]  D. Allen,et al.  Transcriptional regulation of IGF-I expression in skeletal muscle. , 2003, American journal of physiology. Cell physiology.

[18]  Katherine E Yutzey,et al.  NFATc3 and NFATc4 Are Required for Cardiac Development and Mitochondrial Function , 2003, Circulation research.

[19]  J. Molkentin,et al.  Targeted Disruption of NFATc3, but Not NFATc4, Reveals an Intrinsic Defect in Calcineurin-Mediated Cardiac Hypertrophic Growth , 2002, Molecular and Cellular Biology.

[20]  Y. Yoshiko,et al.  Differentiation in C(2)C(12) myoblasts depends on the expression of endogenous IGFs and not serum depletion. , 2002, American journal of physiology. Cell physiology.

[21]  J. DiMaio,et al.  Activation of MEF2 by muscle activity is mediated through a calcineurin‐dependent pathway , 2001, The EMBO journal.

[22]  D. Leroith,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Minireview: Tissue-Specific Versus Generalized Gene Targeting of the igf1 and igf1r Genes and Their Roles in Insulin-Like Growth Factor Physiology , 2022 .

[23]  G. Pavlath,et al.  Altered primary myogenesis in NFATC3(-/-) mice leads to decreased muscle size in the adult. , 2001, Developmental biology.

[24]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[25]  E. Olson,et al.  Independent Signals Control Expression of the Calcineurin Inhibitory Proteins MCIP1 and MCIP2 in Striated Muscles , 2000, Circulation research.

[26]  Lior Pachter,et al.  VISTA : visualizing global DNA sequence alignments of arbitrary length , 2000, Bioinform..

[27]  J. Molkentin,et al.  A Calcineurin-NFATc3-Dependent Pathway Regulates Skeletal Muscle Differentiation and Slow Myosin Heavy-Chain Expression , 2000, Molecular and Cellular Biology.

[28]  Valerie Horsley,et al.  Calcineurin Activity Is Required for the Initiation of Skeletal Muscle Differentiation , 2000, The Journal of cell biology.

[29]  M. Adamo,et al.  Two putative GATA motifs in the proximal exon 1 promoter of the rat insulin-like growth factor I gene regulate basal promoter activity. , 2000, Endocrinology.

[30]  E. Olson,et al.  Stimulation of Slow Skeletal Muscle Fiber Gene Expression by Calcineurin in Vivo * , 2000, The Journal of Biological Chemistry.

[31]  Richard P. Harvey,et al.  Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway , 1999, Nature.

[32]  A. Musarò,et al.  IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1 , 1999, Nature.

[33]  Y. Umayahara,et al.  CCAAT/Enhancer-binding Protein δ Is a Critical Regulator of Insulin-like Growth Factor-I Gene Transcription in Osteoblasts* , 1999, The Journal of Biological Chemistry.

[34]  K. Yutzey,et al.  A GATA-dependent nkx-2.5 regulatory element activates early cardiac gene expression in transgenic mice. , 1998, Development.

[35]  G. Pavlath,et al.  Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. , 1998, Molecular biology of the cell.

[36]  W. Zhu,et al.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. , 1998, Genes & development.

[37]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[38]  Tak W. Mak,et al.  Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum , 1998, Nature.

[39]  Michael J. Grusby,et al.  The transcription factor NF-ATc is essential for cardiac valve formation , 1998, Nature.

[40]  M. Adamo,et al.  Characterization of the rat insulin-like growth factor I gene promoters and identification of a minimal exon 2 promoter. , 1997, Endocrinology.

[41]  Christoph W. Turck,et al.  Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3 , 1997, Science.

[42]  P. Rotwein,et al.  Essential promoter elements are located within the 5′ untranslated region of human insulin-like growth factor-I exon I , 1997, Molecular and Cellular Endocrinology.

[43]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[44]  J R Florini,et al.  Growth hormone and the insulin-like growth factor system in myogenesis. , 1996, Endocrine reviews.

[45]  Y. Umayahara,et al.  Identification of the cAMP Response Element That Controls Transcriptional Activation of the Insulin-like Growth Factor-I Gene by Prostaglandin E2 in Osteoblasts* , 1996, The Journal of Biological Chemistry.

[46]  J. Sussenbach,et al.  Hepatocyte nuclear factor 1 alpha activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites. , 1995, Molecular endocrinology.

[47]  M. Cervera,et al.  Determination of the Consensus Binding Site for MEF2 Expressed in Muscle and Brain Reveals Tissue-specific Sequence Constraints (*) , 1995, The Journal of Biological Chemistry.

[48]  Daryl J. Thomas,et al.  NFATc3, a Lymphoid-specific NFATc Family Member That Is Calcium-regulated and Exhibits Distinct DNA Binding Specificity (*) , 1995, The Journal of Biological Chemistry.

[49]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[50]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[51]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[52]  D. Bichell,et al.  Multifactorial regulation of IGF‐I gene expression , 1993, Molecular reproduction and development.

[53]  S. Orkin,et al.  DNA-binding specificity of GATA family transcription factors , 1993, Molecular and cellular biology.

[54]  J. D. Engel,et al.  DNA-binding specificities of the GATA transcription factor family , 1993, Molecular and cellular biology.

[55]  C. Roberts,et al.  Tissue-specific transcription start site usage in the leader exons of the rat insulin-like growth factor-I gene: evidence for differential regulation in the developing kidney. , 1992, Endocrinology.

[56]  D. Bichell,et al.  Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter. , 1992, DNA and cell biology.

[57]  Y. Jan,et al.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.

[58]  W. Snodgrass.  Physiology , 1897, Nature.